Clinical Trial Update: Management of Cardiovascular Risk Factors

View source ↗

Summary

AstraZeneca reports that a clinical trial evaluating management of cardiovascular risk factors and cardiovascular diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: AstraZeneca | Conditions: Cardiovascular Risk Factors, Cardiovascular Diseases | Status: COMPLETED